Td Ameritrade Investment Management, LLC Biomarin Pharmaceutical Inc Transaction History

Td Ameritrade Investment Management, LLC

  • $0
  • Q3 2023

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$80.93 - $108.63 $4,370 - $5,866
-54 Reduced 71.05%
22 $2,000
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $4,683 - $5,525
-57 Reduced 42.86%
76 $6,000
Q2 2022

Aug 09, 2022
SELL
$71.48 - $86.85 $1,286 - $1,563
-18 Reduced 11.92%
133 $11,000
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $891 - $1,112
12 Added 8.63%
151 $12,000
Q4 2021

Feb 11, 2022
BUY
$71.72 - $91.47 $6,813 - $8,689
95 Added 215.91%
139 $12,000
Q3 2021

Nov 12, 2021
SELL
$74.77 - $85.47 $2,691 - $3,076
-36 Reduced 45.0%
44 $3,000
Q2 2021

Aug 16, 2021
BUY
$75.51 - $84.79 $3,171 - $3,561
42 Added 110.53%
80 $7,000
Q4 2020

Feb 10, 2021
SELL
$72.61 - $90.2 $435 - $541
-6 Reduced 13.64%
38 $3,000
Q2 2020

Aug 14, 2020
SELL
$79.55 - $124.22 $397 - $621
-5 Reduced 10.2%
44 $5,000
Q1 2020

May 13, 2020
SELL
$71.37 - $96.85 $999 - $1,355
-14 Reduced 22.22%
49 $4,000
Q4 2019

Feb 07, 2020
BUY
$64.27 - $86.37 $3,727 - $5,009
58 Added 1160.0%
63 $5,000
Q3 2019

Nov 07, 2019
BUY
$67.4 - $85.11 $337 - $425
5 New
5 $0
Q1 2019

May 15, 2019
SELL
$84.2 - $98.62 $1,936 - $2,268
-23 Closed
0 $0
Q4 2018

Feb 13, 2019
BUY
$80.14 - $106.07 $881 - $1,166
11 Added 91.67%
23 $2,000
Q3 2018

Nov 14, 2018
BUY
$93.92 - $105.72 $187 - $211
2 Added 20.0%
12 $1,000
Q2 2018

Aug 10, 2018
BUY
$76.01 - $99.03 $760 - $990
10 New
10 $1,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Td Ameritrade Investment Management, LLC Portfolio

Follow Td Ameritrade Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email